Growth Metrics

Haemonetics (HAE) Change in Accured Expenses (2016 - 2025)

Haemonetics has reported Change in Accured Expenses over the past 17 years, most recently at -$6.7 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 302.36% year-over-year to -$6.7 million; the TTM value through Dec 2025 reached -$19.3 million, down 251.75%, while the annual FY2025 figure was -$19.2 million, 143.08% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$6.7 million at Haemonetics, down from $17.7 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $49.5 million in Q1 2024 and troughed at -$47.9 million in Q2 2025.
  • A 5-year average of $51750.0 and a median of $3.9 million in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 12477.3% in 2021 and later soared 836.31% in 2022.
  • Year by year, Change in Accured Expenses stood at $3.8 million in 2021, then soared by 89.79% to $7.3 million in 2022, then crashed by 424.4% to -$23.7 million in 2023, then surged by 113.96% to $3.3 million in 2024, then tumbled by 302.36% to -$6.7 million in 2025.
  • Business Quant data shows Change in Accured Expenses for HAE at -$6.7 million in Q4 2025, $17.7 million in Q3 2025, and -$47.9 million in Q2 2025.